Assembly for a Drug Delivery Device and Drug Delivery Device

ABSTRACT

An assembly for a drug delivery device ( 1 ) comprises a housing ( 5 ), a rotation member ( 15 ), a drive member ( 16 ) and at least one correction member ( 7 ). The rotation member ( 15 ) is adapted to be rotated with respect to the housing ( 5 ) in a first rotational direction for delivering a dose of a drug ( 11 ). The drive member ( 16 ) is coupleable to the rotation member ( 15 ) for delivering the dose. In a delivery mode, the drive member ( 16 ) and the rotation member ( 15 ) are coupled such that the drive member ( 16 ) follows rotational movement of the rotation member ( 15 ) in the first rotational direction due to mechanical interaction of the rotation member ( 15 ) and the drive member ( 16 ). In a correction mode, the rotation member ( 15 ) and the drive member ( 16 ) are decoupled such that the rotation member ( 15 ) is rotatable in the first rotational direction with respect to the drive member ( 16 ). For switching from the delivery mode into the correction mode, the correction member ( 7 ) is movable with respect to the housing ( 5 ), wherein the assembly is configured such that movement of the correction member ( 7 ) with respect to the housing ( 5 ) is converted into a relative movement between the drive member ( 16 ) and the rotation member ( 15 ) for decoupling the drive member ( 16 ) and the rotation member ( 15 ).

This disclosure relates to an assembly for a drug delivery device and adrug delivery device incorporating such an assembly.

In a drug delivery device a bung within a cartridge that contains a drugmay be provided. The bung may be displaced with respect to the cartridgefor delivering a set dose of the drug from the cartridge. In general, itis desirable that the delivered dose of the drug matches the dose whichwas previously set by a user, i.e. the dose accuracy should be high.Furthermore, it is desirable that an incorrectly set dose of the drugcan be adjusted, in particular corrected, by the user such that the doseof the drug dispensed afterwards matches exactly the desired dose.

Drug delivery devices are described in documents WO 2008/031238 A1 andUS 2007/0197976 A1, for example.

It is an object of the present disclosure to provide an assemblyfacilitating provision of a novel, preferably an improved, drug deliverydevice.

This object may be achieved by the subject matter of the independentclaim. Further features and advantageous embodiments are the subjectmatter of the dependent claims.

According to one aspect an assembly for a drug delivery device isprovided. The assembly may comprise a housing. The assembly may comprisea rotation member. The rotation member may be adapted to be rotated withrespect to the housing in a first rotational direction for delivering adose of a drug. The first rotational direction may be counter-clockwise,for example. The assembly may comprise a drive member. The drive membermay be, preferably releasably, coupleable to the rotation member fordelivering the dose. The assembly may comprise at least one correctionmember. In a delivery mode, the drive member and the rotation member areexpediently coupled such that the drive member follows rotationalmovement of the rotation member in the first rotational direction due tomechanical interaction of the rotation member and the drive member, e.g.the rotation member and the drive member may be rotationally locked. Inthe delivery mode, the rotation member and, hence, the drive member mayrotate about a common rotation axis. The rotation axis may be a mainlongitudinal axis of the housing. In a correction mode, the rotationmember and the drive member are expediently decoupled such that therotation member is rotatable in the first rotational direction withrespect to the drive member. In the correction mode, the rotation memberand the drive member are expediently rotationally unlocked. Forswitching from the delivery mode into the correction mode, thecorrection member may be movable, preferably radially inwardly, withrespect to the housing. The assembly may be configured such thatmovement, preferably radial inward movement, of the correction memberwith respect to the housing is converted into a relative movement,preferably a relative axial movement, between the drive member and therotation member for decoupling the drive member and the rotation member.

A further aspect relates to a drug delivery device. The drug deliverydevice expediently comprises the assembly described above. The drugdelivery device may comprise a cartridge. The cartridge may hold aplurality of doses of a drug. The assembly may provide a dose correctionmechanism. The dose correction mechanism may allow for correcting a setdose of the drug.

The dose correction mechanism expediently enables correction of apreviously, in particular not correctly, set dose of the drug withoutdrug being dispensed from the cartridge during the correction action. Inthis way, provision of an easily handled, user-friendly drug deliverydevice providing high dose accuracy is facilitated.

For switching into the correction mode, the user may push onto thecorrection member, thereby displacing the correction member with respectto the housing. The, preferably radial inward, movement of thecorrection member may be converted into axial movement of the rotationmember and the drive member relatively to each other and with respect tothe housing. Relative movement of the rotation member and the drivemember may comprise axial movement of the drive member with respect tothe rotation member. In this case, the rotation member may be stationarywith respect to the housing. Additionally or alternatively, relativemovement of the rotation member and the drive member may comprise axialmovement of the rotation member with respect to the drive member. Inthis case, the drive member may be stationary with respect to thehousing.

Due to said relative decoupling movement the rotation member and drivemember may be decoupled, e.g. disengaged. In particular, the drivemember and the rotation member are no longer rotationally locked due tothe relative movement of the rotation member and the drive member. Whenthe rotation member and the drive member are decoupled, the device maybe in the correction mode. The set dose of the drug can now easily becorrected. Rotational movement of the drive member is prevented. In thisway, a user-friendly drug delivery device is achieved.

According to an embodiment, in a setting mode, the rotation member isadapted to be rotated in a second rotational direction with respect tothe drive member for setting a dose of a drug. The second rotationaldirection may be opposite to the first rotational direction. The secondrotational direction may be clockwise, for example. In the delivery modeand/or in the setting mode, the drive member and the rotation member maybe coupled to one another, e.g. engaged, by means of a uni-directionalfriction clutch mechanism, for example a slipping clutch. The frictionclutch mechanism may be configured to prevent relative rotationalmovement of the rotation member and the drive member during rotation ofthe rotation member in the first rotational direction, e.g. in thedelivery mode. The friction clutch mechanism may be configured to permitrelative rotational movement between the rotation member and the drivemember during rotation of the rotation member in the second rotationaldirection, e.g. in the setting mode.

In the setting mode, the rotation member and the drive member areexpediently coupled, in particular engaged, by means of theuni-directional friction clutch mechanism. However, the drive member maybe prevented from following rotation of the rotation member in thesecond rotational direction. This may help to increase dose accuracy.

In the delivery mode, the rotation member and the drive member may alsobe coupled, in particular engaged, by means of the uni-directionalfriction clutch mechanism. The drive member may follow rotation of therotation member in the first rotational direction due to mechanicalcooperation of the drive member and the rotation member for deliveringthe set dose.

In the correction mode, the rotation member may again rotate in thefirst rotational direction. However, in the correction mode, therotation member and the drive member are expediently decoupled, inparticular disengaged, and, hence, the drive member may be preventedfrom following rotation of the rotation member in the first rotationaldirection. Hence, in the correction mode, the rotation member may rotatein the first rotational direction without movement of the drive member.In this way, correction of a not correctly set dose of the drug isfacilitated.

According to an embodiment, a stop member is provided. The drive memberand the stop member are coupled, preferably permanently coupled, to oneanother by an other uni-directional friction clutch mechanism, forexample a slipping clutch. The friction clutch mechanism is expedientlyconfigured to permit relative rotational movement between the stopmember and the drive member during rotation of the rotation member inthe first rotational direction, e.g. in the delivery mode. The clutchmechanism may be configured to prevent relative rotational movementbetween the drive member and the stop member during rotation of therotation member in the second rotational direction, e.g. in the settingmode.

Due to mechanical cooperation of the stop member and the drive member,movement, in particular rotation, of the drive member is prevented whensetting the dose. This may help to increase dose accuracy.

According to an embodiment, a piston rod is provided. The drive memberand the piston rod may be rotationally locked with each other.

The piston rod may be configured to displace the bung with respect tothe cartridge for expelling the set dose of the drug from the cartridge.Preferably, the piston rod is splined to the drive member. Inparticular, rotational movement of the drive member in the firstrotational direction may be converted into movement of the piston rodwith respect to the housing due to the splined connection of the drivemember and the piston rod.

In the setting mode, the drive member is prevented from rotating withrespect to the housing due to mechanical cooperation with the stopmember. In the correction mode, the drive member is prevented fromrotating with respect to the housing due to decoupling, in particulardisengagement, of the drive member and the rotation member.Consequently, in the setting mode and in the correction mode, movementof the piston rod is prevented due to the splined connection of thepiston rod and the drive member. In this way, dose accuracy may beincreased.

According to an embodiment, for switching into the correction mode, thedrive member and the rotation member are moved relatively to each otherand with respect to the piston rod for decoupling the rotation memberand the drive member. When the drive member is moved with respect to therotation member, the stop member is expediently moved together with thedrive member.

According to an embodiment, in the delivery mode and in the settingmode, the rotation member and/or the stop member is held in abutment,preferably permanent abutment, with the drive member by a force providedby a resilient member. Preferably, the resilient member is a springmember, for example a helical coil spring. The resilient member mayexert a force onto the stop member, the drive member and the rotationmember when setting, correcting and delivering the dose. Preferably, theforce is exerted along the rotation axis. Preferably, the rotation axisruns along a main direction of extent of the piston rod.

According to an embodiment, for switching into the correction mode, acorrection force must be applied, said force acting against the forceexerted by the resilient member.

The correction force must be applied against the force exerted by theresilient member in order to move the rotation member and the drivemember relatively to each other for decoupling the drive member and therotation member. The correction force is expediently exerted along therotation axis and preferably in the opposite direction compared to theforce exerted by the resilient member. If the correction force is nolonger exerted, e.g. after the correction has been completed, therotation member and the drive member may be brought re-coupledautomatically by the resilient member. In this way, automatic switchfrom the correction mode into the delivery and/or setting mode isfacilitated. Thus, a user-friendly drug delivery device is achieved.

According to an embodiment, at least one of the drive member and therotation member comprises at least one interaction element. Forswitching into the correction mode, the correction member maymechanically interact with the interaction element. Movement of thecorrection member may be converted into relative movement between thedrive member and the rotation member by mechanical interaction of thecorrection member and the interaction element.

If relative movement between the drive member and the rotation membercomprises movement of the drive member with respect to the rotationmember, the interaction element may be part of or fixed to the drivemember. Additionally or alternatively, if the rotation member is movedwith respect to the drive member for decoupling the drive member and therotation member, the interaction element may be part of or may be fixedto the rotation member. Preferably, the interaction element is unitarilyformed with the drive member and/or the rotation member.

According to an embodiment, the interaction element has an oblique outerface. The outer face may be oblique with respect to the mainlongitudinal axis of the housing. The outer face may runcircumferentially around the interaction element. The correction membermay exert a radially, preferably radially inwardly, directed force ontothe interaction element for switching into the correction mode. Theforce may be converted into an axially directed force, e.g. thecorrection force, by mechanical cooperation of the correction member andthe oblique outer face.

According to an embodiment, the correction member is secured againstrotational movement with respect to the housing. The correction membermay be secured against movement along the main longitudinal axis of thehousing. The correction member and the interaction element expedientlyaxially overlap, in particular when the rotation member is coupled tothe drive member, e.g. in the setting mode and in the delivery mode.

Preferably, the correction member is secured to the housing such thatradial movement of the correction member with respect to the mainlongitudinal axis of the housing is allowed while rotational movementand movement along the main longitudinal axis of the housing isexpediently prevented. Preferably, the correction member is a switchcorrection button.

According to an embodiment, the correction member is externallyactuatable.

In this way, provision of a user-friendly drug delivery device isfacilitated enabling an easy and quick correction of an incorrectly setdose of the drug.

According to an embodiment, the correction member is a resilient memberor a resiliently mounted member.

Preferably, the correction member comprises or is embodied as adeformable, in particular an elastically deformable, member. In thisway, automatic switching from the correction mode back into the deliverymode may be enabled once the correction member is released, for example,due to the restoring force which may move the correction member backinto the initial position.

According to an embodiment, two equally configured correction membersmay be provided. The correction members may be disposed oppositely.

Preferably, the correction members are arranged such that a user caneasily push onto the correction members using only two fingers forswitching into the correction mode. Thus, provision of an easily handleddrug delivery device is facilitated.

According to a preferred embodiment, an assembly for a drug deliverydevice is provided. The assembly comprises a housing. The assemblycomprises a rotation member, the rotation member being adapted to berotated with respect to the housing in a first rotational direction fordelivering a dose of a drug. The assembly comprises a drive member, thedrive member being coupleable to the rotation member for delivering thedose. The assembly comprises at least one correction member. In adelivery mode, the drive member and the rotation member are coupled suchthat the drive member follows rotational movement of the rotation memberin the first rotational direction due to mechanical interaction of therotation member and the drive member. In a correction mode, the rotationmember and the drive member are decoupled such that the rotation memberis rotatable in the first rotational direction with respect to the drivemember. For switching from the delivery mode into the correction mode,the correction member is movable with respect to the housing, whereinthe assembly is configured such that movement of the correction memberwith respect to the housing is converted into a relative movementbetween the drive member and the rotation member for decoupling thedrive member and the rotation member.

In this way, correction of a previously, in particular not correctly,set dose of the drug is facilitated. Thus, an easily handled anduser-friendly drug delivery device is achieved.

Of course, features described above in connection with different aspectsand embodiments may be combined with each other and with featuresdescribed below.

Further features and refinements become apparent from the followingdescription of the exemplary embodiments in connection with theaccompanying figures.

FIG. 1 schematically shows a perspective sectional view of an exemplaryembodiment of a drug delivery device,

FIG. 2 schematically shows a sectional side view of the drug deliverydevice of FIG. 1,

FIG. 3 schematically shows a perspective sectional view of the drugdelivery device shown in FIG. 1 in the setting mode,

FIG. 4 schematically shows a perspective sectional view of the drugdelivery device of FIG. 3 while switching into the correction mode, and

FIG. 5 schematically shows a perspective sectional view of the drugdelivery device of FIG. 4 in the correction mode.

Like elements, elements of the same kind and identically acting elementsmay be provided with the same reference numerals in the figures.

In FIG. 1, a drug delivery device 1 is shown. The drug delivery device 1comprises a cartridge holder 2. The device 1 comprises a cartridge 3.The cartridge 3 is retained in the cartridge holder 2. The cartridgeholder 2 stabilizes the cartridge 3 mechanically.

The cartridge 3 may hold a plurality of doses of a drug (see drug 11,FIG. 2). The drug 11 is preferably a liquid medication, comprising, forexample, insulin, like short-acting or long-acting insulin, heparinand/or growth hormones. The term “drug”, as used herein, preferablymeans a pharmaceutical formulation containing at least onepharmaceutically active compound,

wherein in one embodiment the pharmaceutically active compound has amolecular weight up to 1500 Da and/or is a peptide, a proteine, apolysaccharide, a vaccine, a DNA, a RNA, an enzyme, an antibody, ahormone or an oligonucleotide, or a mixture of the above-mentionedpharmaceutically active compound,

wherein in a further embodiment the pharmaceutically active compound isuseful for the treatment and/or prophylaxis of diabetes mellitus orcomplications associated with diabetes mellitus such as diabeticretinopathy, thromboembolism disorders such as deep vein or pulmonarythromboembolism, acute coronary syndrome (ACS), angina, myocardialinfarction, cancer, macular degeneration, inflammation, hay fever,atherosclerosis and/or rheumatoid arthritis,

wherein in a further embodiment the pharmaceutically active compoundcomprises at least one peptide for the treatment and/or prophylaxis ofdiabetes mellitus or complications associated with diabetes mellitussuch as diabetic retinopathy,

wherein in a further embodiment the pharmaceutically active compoundcomprises at least one human insulin or a human insulin analogue orderivative, glucagon-like peptide (GLP-1) or an analogue or derivativethereof, or exedin-3 or exedin-4 or an analogue or derivative ofexedin-3 or exedin-4.

Insulin analogues are for example Gly(A21), Arg(B31), Arg(B32) humaninsulin; Lys(B3), Glu(B29) human insulin; Lys(B28), Pro(B29) humaninsulin; Asp(B28) human insulin; human insulin, wherein proline inposition B28 is replaced by Asp, Lys, Leu, Val or Ala and wherein inposition B29 Lys may be replaced by Pro; Ala(B26) human insulin;Des(B28-B30) human insulin; Des(B27) human insulin and Des(B30) humaninsulin.

Insulin derivates are for example B29-N-myristoyl-des(B30) humaninsulin; B29-N-palmitoyl-des(B30) human insulin; B29-N-myristoyl humaninsulin; B29-N-palmitoyl human insulin; B28-N-myristoyl LysB28ProB29human insulin; B28-N-palmitoyl-LysB28ProB29 human insulin;B30-N-myristoyl-ThrB29LysB30 human insulin; B30-N-palmitoyl-ThrB29LysB30human insulin; B29-N-(N-palmitoyl-Y-glutamyl)-des(B30) human insulin;B29-N-(N-lithocholyl-Y-glutamyl)-des(B30) human insulin;B29-N-(ω-carboxyheptadecanoyl)-des(B30) human insulin andB29-N-(ω-carboxyheptadecanoyl) human insulin.

Exendin-4 for example means Exendin-4(1-39), a peptide of the sequenceH-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2.

Exendin-4 derivatives are for example selected from the following listof compounds:

H-(Lys)4-des Pro36, des Pro37 Exendin-4(1-39)-NH2,

H-(Lys)5-des Pro36, des Pro37 Exendin-4(1-39)-NH2,

des Pro36 [Asp28] Exendin-4(1-39),

des Pro36 [IsoAsp28] Exendin-4(1-39),

des Pro36 [Met(O)14, Asp28] Exendin-4(1-39),

des Pro36 [Met(O)14, IsoAsp28] Exendin-4(1-39),

des Pro36 [Trp(O2)25, Asp28] Exendin-4(1-39),

des Pro36 [Trp(O2)25, IsoAsp28] Exendin-4(1-39),

des Pro36 [Met(O)14 Trp(O2)25, Asp28] Exendin-4(1-39),

des Pro36 [Met(O)14 Trp(O2)25, IsoAsp28] Exendin-4(1-39); or

des Pro36 [Asp28] Exendin-4(1-39),

des Pro36 [IsoAsp28] Exendin-4(1-39),

des Pro36 [Met(O)14, Asp28] Exendin-4(1-39),

des Pro36 [Met(O)14, IsoAsp28] Exendin-4(1-39),

des Pro36 [Trp(O2)25, Asp28] Exendin-4(1-39),

des Pro36 [Trp(O2)25, IsoAsp28] Exendin-4(1-39),

des Pro36 [Met(O)14 Trp(O2)25, Asp28] Exendin-4(1-39),

des Pro36 [Met(O)14 Trp(O2)25, IsoAsp28] Exendin-4(1-39),

wherein the group -Lys6-NH2 may be bound to the C-terminus of theExendin-4 derivative;

or an Exendin-4 derivative of the sequence

H-(Lys)6-des Pro36 [Asp28] Exendin-4(1-39)-Lys6-NH2,

des Asp28 Pro36, Pro37, Pro38Exendin-4(1-39)-NH2,

H-(Lys)6-des Pro36, Pro38 [Asp28] Exendin-4(1-39)-NH2,

H-Asn-(Glu)5des Pro36, Pro37, Pro38 [Asp28] Exendin-4(1-39)-NH2,

des Pro36, Pro37, Pro38 [Asp28] Exendin-4(1-39)-(Lys)6-NH2,

H-(Lys)6-des Pro36, Pro37, Pro38 [Asp28] Exendin-4(1-39)-(Lys)6-NH2,

H-Asn-(Glu)5-des Pro36, Pro37, Pro38 [Asp28] Exendin-4(1-39)-(Lys)6-NH2,

H-(Lys)6-des Pro36 [Trp(O2)25, Asp28] Exendin-4(1-39)-Lys6-NH2,

H-des Asp28 Pro36, Pro37, Pro38 [Trp(O2)25] Exendin-4(1-39)-NH2,

H-(Lys)6-des Pro36, Pro37, Pro38 [Trp(O2)25, Asp28] Exendin-4(1-39)-NH2,

H-Asn-(Glu)5-des Pro36, Pro37, Pro38 [Trp(O2)25, Asp28]Exendin-4(1-39)-NH2,

des Pro36, Pro37, Pro38 [Trp(O2)25, Asp28] Exendin-4(1-39)-(Lys)6-NH2,

H-(Lys)6-des Pro36, Pro37, Pro38 [Trp(O2)25, Asp28]Exendin-4(1-39)-(Lys)6-NH2,

H-Asn-(Glu)5-des Pro36, Pro37, Pro38 [Trp(O2)25, Asp28]Exendin-4(1-39)-(Lys)6-NH2,

H-(Lys)6-des Pro36 [Met(O)14, Asp28] Exendin-4(1-39)-Lys6-NH2,

des Met(O)14 Asp28 Pro36, Pro37, Pro38 Exendin-4(1-39)-NH2,

H-(Lys)6-desPro36, Pro37, Pro38 [Met(O)14, Asp28] Exendin-4(1-39)-NH2,

H-Asn-(Glu)5-des Pro36, Pro37, Pro38 [Met(O)14, Asp28]Exendin-4(1-39)-NH2,

des Pro36, Pro37, Pro38 [Met(O)14, Asp28] Exendin-4(1-39)-(Lys)6-NH2,

H-(Lys)6-des Pro36, Pro37, Pro38 [Met(O)14, Asp28]Exendin-4(1-39)-(Lys)6-NH2,

H-Asn-(Glu)5 des Pro36, Pro37, Pro38 [Met(O)14, Asp28]Exendin-4(1-39)-(Lys)6-NH2,

H-Lys6-des Pro36 [Met(O)14, Trp(O2)25, Asp28] Exendin-4(1-39)-Lys6-NH2,

H-des Asp28 Pro36, Pro37, Pro38 [Met(O)14, Trp(O2)25]Exendin-4(1-39)-NH2,

H-(Lys)6-des Pro36, Pro37, Pro38 [Met(O)14, Asp28] Exendin-4(1-39)-NH2,

H-Asn-(Glu)5-des Pro36, Pro37, Pro38 [Met(O)14, Trp(O2)25, Asp28]Exendin-4(1-39)-NH2,

des Pro36, Pro37, Pro38 [Met(O)14, Trp(O2)25, Asp28]Exendin-4(1-39)-(Lys)6-NH2,

H-(Lys)6-des Pro36, Pro37, Pro38 [Met(O)14, Trp(O2)25, Asp28]Exendin-4(S1-39)-(Lys)6-NH2,

H-Asn-(Glu)5-des Pro36, Pro37, Pro38 [Met(O)14, Trp(O2)25, Asp28]Exendin-4(1-39)-(Lys)6-NH2;

or a pharmaceutically acceptable salt or solvate of any one of theafore-mentioned Exedin-4 derivative.

Hormones are for example hypophysis hormones or hypothalamus hormones orregulatory active peptides and their antagonists as listed in RoteListe, ed. 2008, Chapter 50, such as Gonadotropine (Follitropin,Lutropin, Choriongonadotropin, Menotropin), Somatropine (Somatropin),Desmopressin, Terlipressin, Gonadorelin, Triptorelin, Leuprorelin,Buserelin, Nafarelin, Goserelin.

A polysaccharide is for example a glucosaminoglycane, a hyaluronic acid,a heparin, a low molecular weight heparin or an ultra low molecularweight heparin or a derivative thereof, or a sulphated, e.g. apoly-sulphated form of the above-mentioned polysaccharides, and/or apharmaceutically acceptable salt thereof. An example of apharmaceutically acceptable salt of a poly-sulphated low molecularweight heparin is enoxaparin sodium.

Pharmaceutically acceptable salts are for example acid addition saltsand basic salts. Acid addition salts are e.g. HCl or HBr salts. Basicsalts are e.g. salts having a cation selected from alkali or alkaline,e.g. Na+, or K+, or Ca2+, or an ammonium ion N+(R1)(R2)(R3)(R4), whereinR1 to R4 independently of each other mean: hydrogen, an optionallysubstituted C1-C6-alkyl group, an optionally substituted C2-C6-alkenylgroup, an optionally substituted C6-C10-aryl group, or an optionallysubstituted C6-C10-heteroaryl group. Further examples ofpharmaceutically acceptable salts are described in “Remington'sPharmaceutical Sciences” 17. ed. Alfonso R. Gennaro (Ed.), MarkPublishing Company, Easton, Pa., U.S.A., 1985 and in Encyclopedia ofPharmaceutical Technology.

Pharmaceutically acceptable solvates are for example hydrates.

The cartridge 3 has an outlet 10, as shown in FIG. 2. The drug 11 can bedispensed from the cartridge 3 through the outlet 10. The outlet 10 maybe covered by a membrane. The membrane may protect the drug 11 againstexternal influences during storage of the cartridge 3.

The drug delivery device 1 may comprise a needle assembly (notexplicitly shown), comprising a needle. The needle assembly may bereleasably attached to the cartridge holder 2, for example by means ofengagement means 4, e.g. a thread. The membrane may be pierced by theneedle for dispensing a dose of the drug 11. Alternatively, the drugdelivery device 1 may be a needle-free device.

The drug delivery device 1 may be an injection device. The drug deliverydevice 1 may be a pen-type device, in particular a pen-type injector.The device 1 may be a disposable or a re-usable device. Preferably, thedevice 1 is configured to dispense variable, preferably user-settable,doses of the drug 11. Alternatively, the device 1 may be a fixed dosedevice, in particular a device configured to dispensed doses of the drug11 which may not be varied by the user. The drug delivery device 1 maybe a manually, in particular a non-electrically, driven device.

The drug delivery device comprises a housing 5. The drug delivery device1 and the housing 5 have a distal end and a proximal end. The term“distal end” designates that end of the drug delivery device 1 or acomponent thereof which is or is to be arranged closest to a dispensingend of the drug delivery device 1. The distal end of the device 1 isindicated by arrow 8. The term “proximal end” designates that end of thedevice 1 or a component thereof which is or is to be arranged furthestaway from the dispensing end of the device 1. The proximal end of thedevice 1 is indicated by arrow 9.

The housing 5 may be designed to enable a safe and comfortable handlingof the drug delivery device 1. The housing 5 may be configured to house,fix, protect or guide inner components of the drug delivery device 1,e.g. components of a drive mechanism, which is described later on inmore detail. Preferably, the housing 5 limits or prevents the exposureof the inner components to contaminants such as liquid, dirt or dust.The housing 5 may be a unitary or a multipart component. The housing 5may comprise a tubular shape, as shown in FIG. 1. Alternatively, thehousing 5 may comprise a non-tubular shape.

The cartridge holder 2 and the housing 5 may be, preferably permanentlyor releasably, secured to one another, for example by a threadedconnection. If the cartridge holder 2 is releasably secured to thehousing 5, the device 1 may be a re-usable device. In this case, thecartridge holder 2 may be detached from the housing 5 for providing anew cartridge 3, if all of the doses of the drug 11 have already beendispensed. Afterwards, the cartridge holder 2 is re-attached to thehousing 5. If the cartridge holder 2 is irreleasably secured to thehousing 5 the drug delivery device 1 may be a disposable device.

The drug delivery device 1 comprises a bung 12 (see FIG. 2). The bung 12may be retained in the cartridge 3. The bung 12 is movable with respectto the cartridge 3. The bung 12 may seal the cartridge 3 proximally.Movement of the bung 12 in the distal direction with respect to thecartridge 3 causes the drug 11 to be dispensed from the cartridge 3through the outlet 10.

The device 1 comprises a piston rod 14 (see FIG. 2). The piston rod 14may operate through the housing 5 of the drug delivery device 1. Thepiston rod 14 may be designed to transfer axial movement through thedrug delivery device 1, for example for the purpose of dispensing thedrug 11. In particular, the piston rod 14 may be designed to transferforce to the bung 12, thereby pushing the bung 12 in the distaldirection with respect to the cartridge 3. In this way, a dose of thedrug 11 may be dispensed from the cartridge 3 provided the outlet 10 isopen, e.g. after the membrane has been pierced by the needle asdescribed above. The size of the dispensed dose is determined by thedistance by which the bung 12 is displaced in the distal direction withrespect to the cartridge 3.

The piston rod 14 may be made of a flexible or a rigid material. Thepiston rod 14 may have a circular or a non-circular cross-section. Thepiston rod 14 may be a simple rod, a lead-screw, a rack, a pinion systemor the like. The piston rod 14 may be of unitary or multipartconstruction.

A bearing member 13 (see FIG. 2) may be arranged between the bung 12 andthe piston rod 14 to advance the bung 12. The bearing member 13 may bedisplaced together with the piston rod 14 with respect to the housing 5.The piston rod 14 may be rotatable with respect to the bearing member13. The bearing member 13 may be axially locked to the piston rod 14,for example by means of a snap-fit connection.

The device 1 comprises a drive mechanism. The drive mechanism isarranged within the housing 5 of the drug delivery device 1. The device1 comprises a dose member 6. The dose member 6 comprises a dose button6A. The dose member 6 may be part of the drive mechanism. The dosemember 6 may be movable with respect to the housing 5. The dose member 6may be splined to the housing 5. The dose member 6 may be movable in theproximal direction with respect to the housing 5 for setting a dose ofthe drug 11. The dose member 6 may be movable in the distal directionwith respect to the housing 5 for delivering the set dose of the drug11. Preferably, the dose member 6 is movable in the distal directionwith respect to the housing 5 for correcting the set dose, e.g. forreducing the size of the dose or for un-setting the dose, which isexplained later on in more detail.

The distance by which the dose member 6 is moved proximally with respectto the housing 5 for setting the dose of the drug 11 may determine thesize of the set dose. A proximal end position and a distal end positionof the dose member 6 with respect to the housing 5 may be determined bya respective stop feature (not explicitly shown) limiting the proximalor distal movement of the dose member 6 with respect to the housing 5.

The dose button 6A may be configured to be pulled by a user for settingthe dose. The dose button 6A may be pushed by the user for dispensingthe set and/or corrected dose. The dose button 6A may be part of thedose member 6 or may be connected to the dose member 6.

A force, preferably a user-applied force, causing the dose member 6 tobe moved distally with respect to the housing 5 may be transferred tothe piston rod 14 by the drive mechanism for dispensing the set dose,which is described later on in more detail. Preferably, the drivemechanism is configured to leave the piston rod 14 stationary withrespect to the housing 5 when the dose member 6 is moved in the proximaldirection with respect to the housing 5 for setting the dose and in thedistal direction with respect to the housing 5 for correcting the setdose.

The drive mechanism comprises a drive member 16. The drive mechanismcomprises a rotation member 15. The drive mechanism comprises a stopmember 20 (see FIGS. 2 to 5).

The rotation member 15 may be axially displaceable with respect to thehousing 5 in a limited fashion, which is described later on in moredetail. The rotation member 15 is rotatable with respect to the housing5. The rotation member 15 may be arranged inside the dose member 6. Thedose member 6 may be coupled to, preferably threadedly engaged with, therotation member 15. For this purpose, the rotation member 15 maycomprise outer thread 15A, as shown in FIG. 2. The dose member 6 maycomprise a counterpart 28, e.g. a thread (see FIG. 2). The counterpart28 may be provided within the dose member 6. The dose member 6 and therotation member 15 may be threadedly engaged such that axial movement ofthe dose member 6 is expediently converted into rotational movement ofthe rotation member 15.

Thus, in a setting mode of the device 1, movement of the dose member 6in the proximal direction with respect to the housing 5 for setting adose of the drug 11 may be converted into rotation of the rotationmember 15 in a second rotational direction with respect to the housing5. The second rotational direction may be clockwise, for example.

In a delivery mode of the device 1, movement of the dose member 6 in thedistal direction with respect to the housing 5 for delivering the setdose may be converted into rotation of the rotation member 15 in a firstrotational direction with respect to the housing 5. The first rotationaldirection may be opposite to the second rotational direction. The firstrotational direction may be counter-clockwise and the second rotationaldirection may be clockwise, for example.

In a correction mode of the device 1, movement of the dose member 6 inthe distal direction with respect to the housing 5 for correcting theset dose may be converted into rotation of the rotation member 15 in thefirst rotational direction with respect to the housing 5.

The drive member 16 may be axially displaceable with respect to thehousing 5 in a limited fashion, which is described later on in moredetail. The drive member 16 is rotatable with respect to the housing 5.The drive member 16 and the rotation member 15 are preferably configuredto rotate about a common rotation axis when delivering the set dose. Therotation axis may be a main longitudinal axis 19 of the housing 5 or thedevice 1. Preferably, the rotation axis runs along the piston rod 14and, in particular, along a main direction of extent of the piston rod14.

The rotation member 15 may be coupled, for example engaged, preferablypermanently, to the drive member 16 when the device 1 is in the settingmode. The rotation member 15 may be coupled, preferably permanently, tothe drive member 16 when the device 1 is in the delivery mode. However,the rotation member 15 and the drive member 16 are preferably decoupled,in particular disengaged, when the device 1 is in the correction mode,e.g. for correcting an erroneously set dose of the drug 11, which isdescribed later on in more detail.

In the setting mode and in the delivery mode, the rotation member 15 iscoupled to the drive member 16 by a uni-directional clutch mechanism, inparticular a friction clutch mechanism, for example a slipping clutch.The clutch mechanism permits rotational movement of the rotation member15 with respect to the drive member 16 when the rotation member 15rotates in the second rotational direction with respect to the housing5, e.g. in the setting mode. The clutch mechanism prevents rotationalmovement of the rotation member 15 with respect to the drive member 16,when the rotation member 15 rotates in the first rotational directionwith respect to the housing 5, e.g. in the delivery mode.

In the setting mode and in the delivery mode, the drive member 16 may bearranged to abut or engage the rotation member 15. For engaging therotation member 15, the drive member 16 comprises a toothing 22 (seeFIG. 3). Toothing 22 may be arranged in the proximal end section of thedrive member 16, for example. In addition, the rotation member 15comprises a toothing 21 (see in FIG. 3). Toothing 21 may be arranged inthe distal end section of the rotation member 15, for example. Inparticular, toothing 21 may be arranged at an end section of therotation member 15 which faces the drive member 16. Toothing 21 andtoothing 22 may be configured to mate with each other. Toothing 21comprises a plurality of teeth. The teeth of toothing 21 may be disposedalong a perimeter of the rotation member 15. The teeth of toothing 22may be disposed along a perimeter of the drive member 16. Toothing 22comprises a plurality of teeth. The teeth of the respective toothing 20,21 may extend along the rotation axis.

A respective tooth of toothing 20, 21 may be ramp-shaped, in particularalong an azimuthal direction with respect to the rotation axis. The rampof the respective tooth is limited in the azimuthal direction by a steepend face of said tooth, e.g. a face of the tooth that runs parallel tothe rotation axis. When the steep end faces of two respective teeth oftoothing 20 and 21 abut and the rotation member 15 is rotated further inthe first rotational direction with respect to the housing 5, the steepsides stay in abutment and, hence, the drive member 16 follows rotationof the rotation member 15.

When the rotation member 15 rotates in the second rotational directionwith respect to the housing 5, the ramps of the teeth of toothing 20 and21 slide along each other and, hence, the rotation member 15 rotateswith respect to the drive member 16. Accordingly, the device 1 is in thesetting mode. An audible and/or tactile feedback may be given to theuser when the next tooth of toothings 20, 21 engage with each other.

The drive member 16 engages the piston rod 14. Preferably, the drivemember 16 is splined to the piston rod 14. The splined connection of thedrive member 16 and the piston rod 14 prevents relative rotationalmovement of the drive member 16 with respect to piston rod 14. Hence,the drive member 16 and the piston rod 14 are permanently rotationallylocked.

The drive member 16 is configured to transfer force, preferably torque,to the piston rod 14. The force transferred may cause the piston rod 14to be rotated with respect to the housing 5. Additionally oralternatively, the force transferred may cause the piston rod 14 to bedisplaced in the distal direction with respect to the housing 5 fordelivering the set dose of the drug 11.

The piston rod 14 comprises a thread 14A. The thread 14A may be arrangedat an outer surface of the piston rod 14. A counterpart, e.g. a furtherthread, may be provided inside the housing 5 for a threaded engagementof the housing 5 and piston rod 14. Rotational movement of the pistonrod 14 may be converted into axial movement of the piston rod 14 in thedistal direction with respect to the housing 5 due to the threadedengagement of the piston rod 14 and the housing 5.

The drive member 16 may be arranged between stop member 20 and rotationmember 15. The stop member 20 is configured to prevent rotationalmovement of the drive member 16 in the second rotational direction withrespect to the housing 5 when setting the dose of the drug 11.Consequently, in the setting mode, the rotation member 15 rotates withrespect to the drive member 16 and with respect to the stop member 20.The stop member 20 is preferably secured against rotation with respectto the housing 5 or integrally formed with respect to the housing 5. Thestop member 20 may be axially displaceable with respect to the housing5. The stop member 20 may be splined to the housing 5.

The stop member 20 may be coupled to the drive member 16 by means of afurther uni-directional clutch mechanism, for example a slipping clutch.The clutch mechanism prevents rotational movement of the drive member 16with respect to the stop member 20 when the rotation member 15 rotatesin the second rotational direction with respect to the housing, e.g.when setting the dose of the drug 11. The clutch mechanism permitsrotational movement of the drive member 16 with respect to the stopmember 20 when the rotation member 15 rotates in the first rotationaldirection with respect to the housing 5, e.g. when delivering the setdose of the drug 11.

The stop member 20 may be arranged to abut or engage the drive member16, preferably when setting, when correcting and when delivering the setdose, e.g. in either operation mode of the device 1. The stop member 20comprises a toothing 24 (see FIG. 3) at one end section which faces thedrive member 16, for example the proximal end section of the stop member20. The teeth of toothing 24 may be ramp-shaped and may be disposedalong a perimeter of the stop member 20.

The drive member 16 comprises a further toothing 23 (see FIG. 3),preferably at the distal end section of the drive member 16. Thereby,toothing 23 and toothing 22 of the drive member 16 are disposedoppositely. Toothing 23 may be configured in accordance with toothing 21of the rotation member 15. Toothing 23 and toothing 24 may be configuredto cooperate for preventing rotation of the drive member 16 with respectto the housing 5 and with respect to the stop member 20 when setting thedose of the drug 11.

As rotation of the drive member 16 in the second rotational directionwith respect to the housing 5 is prevented, movement of the piston rod14 in the proximal direction with respect to the housing 5 as well asrotation of the piston rod 14 in the second rotational direction withrespect to the housing 5 during setting of the dose is prevented. Thismay help to increase dose accuracy.

The drive mechanism further comprises a resilient member 18, for examplea spring member. Preferably, resilient member 18 is a helical coilspring. The resilient member 18 provides a force which tends to keep thedrive member 16 in permanent mechanical cooperation, e.g. engagement,with the stop member 20 and the rotation member 15, when the device 1 isin the delivery mode, in the correction mode and in the setting mode,e.g. in either operation mode of the device 1. Preferably, the force isexerted along the rotation axis.

The drive member 16, the rotation member 15, the stop member 20 and thedose member 6 may comprise or may be embodied as a sleeve, respectively.The piston rod 14 may be arranged and/or driven through at least one, ormore, or all of said sleeves.

The drive member 16 comprises at least one interaction element 17.Preferably, the interaction element 17 is arranged in the distal endsection of the drive member 16, as indicated in FIG. 2. The interactionelement 17 is provided around the drive member 16. Preferably, the drivemember 16 and the interaction element 17 are unitarily formed.

The interaction element 17 comprises a skirt 17B. Skirt 17B may beembodied as or may comprise a ring-like portion, for example. Skirt 17Bmay extend along the main longitudinal axis 19 of the housing 5. Theskirt 17B comprises an oblique outer face 17A. The oblique outer face17A is preferably arranged in the distal end section of the skirt 17B.The oblique outer face 17A may be oblique with respect to the mainlongitudinal axis 19 of the housing 5. The oblique outer face 17A mayrun around the drive member 16, preferably along its whole perimeter,and/or around the main longitudinal axis.

The device 1 comprises at least one correction member 7. Preferably, thedevice 1 comprises two correction members 7, as indicated in FIG. 2. Thecorrection members 7 may be equally configured. The correction members 7may be user actuatable, e.g. by pushing onto the correction members 7.The correction members 7 may be disposed oppositely such that the usercan easily push onto the correction members 7 with two fingers, e.g. thethumb and index finger. Alternatively, the device 1 comprises three ormore correction members 7. Preferably, the correction members 7 compriseor are embodied as switch buttons for switching the device 1 into thecorrection mode.

The correction members 7 are secured against rotation with respect tothe housing 5. The correction members 7 are secured against movementalong the main longitudinal axis 19 of the housing 5. However, thecorrection members 7 may be adapted to be radially movable with respectto the housing 5.

The respective correction member 7 comprises a disc-like portion 7A. Thedisc-like portion 7A is preferably arranged at an outer surface of thehousing 5 such that the user is able to push onto the disc-like portion7A. Consequently, the respective correction member 7 is externallyacuatable, in particular user actuatable. When the respective correctionmember 7 is released by the user, the device 1 may be automaticallyswitched from the correction mode into the delivery mode or back intothe setting mode, for example.

The correction members 7 comprise a protruding portion 7B. Preferably,the disc-like portion 7A and the protruding portion 7B are formedunitarily. The protruding portion 7B protrudes radially inwardly withrespect to the housing 5. The protruding portion 7B may comprise a tiparranged at the end of the protruding portion 7B being furthest awayfrom the disc-like portion 7A.

The correction members 7, in particular the protruding portion 7B, areconfigured to mechanically interact with the interaction element 17, inparticular with the oblique outer face 17A, for switching the device 1into the correction mode. Preferably, the correction members 7 axiallyoverlap with the oblique outer face 17A. Preferably, the axial positionof the respective correction member 7 with respect to the housing 5 isdefined by that axial position the respective interaction element 17, inparticular the oblique outer face 17A, has with respect to the housing 5when the drive member 16 and the rotation member 15 are coupled witheach other. Thus, the respective correction member 7 may mechanicallyinteract with the respective interaction element 17, in particular withthe oblique outer face 17A, when the correction member 7 is moved withrespect to the housing 5.

Preferably, the correction members 7 are resilient members, inparticular elastically deflectable members. Alternatively, thecorrection members 7 may be resiliently mounted members. In this case, aspring member, for example a coil spring, may be arranged between thedisc-like portion 7A and the protruding portion 7B. The spring membermay be biased radially inwardly when the correction member 7 is pushedinwardly by the user. The biased spring member may relax radiallyoutwardly, when the disc-like portion 7A is released, e.g. after havingcorrected the dose, thereby displacing the correction member 7automatically radially outwardly. In this way, the device 1 may beautomatically switched from the correction mode back into the settingmode or into the delivery mode when the respective correction member 7is released.

For switching into the correction mode (see also FIG. 4), the correctionmembers 7, in particular the disc-like portion 7A, are pushed by theuser. Thereby, the correction members 7 are displaced radially inwardlywith respect to the housing 5 and towards the oblique outer face 17A.The spring member is thus biased radially inwardly.

When the correction members 7 are displaced radially inwardly, the tipof the protruding portion 7B may abut the oblique outer face 17A.Thereby, the correction members 7 exert a radially inwardly directedforce onto the interaction element 17. The radially inwardly directedforce is converted into an axially directed force, e.g. a correctionforce, by mechanical cooperation of the tip of the protruding portion 7Band the oblique outer face 17A, which tip is moved along the obliqueouter face 17A.

In particular, the oblique outer face 17A may be adapted to mechanicallyinteract with the correction member 7, in particular with the tip of theprotruding portion 7B, such that radial inward movement of thecorrection member 7 with respect to the housing 5 is converted intodistal movement of the drive member 16 and, thus, of the stop member 20,with respect to the housing 5 and with respect to the rotation member 15(see FIG. 4) for decoupling the drive member 16 and the rotation member15.

Accordingly, movement of the correction members 7 in the radial inwarddirection with respect to the housing 5 is converted into a relative(axial) movement between the drive member 16 and the rotation member 15for decoupling the drive member 16 and the rotation member 15.

When the drive member 16 and, hence, the stop member 20 are displaceddistally with respect to the rotation member 15, the user-appliedcorrection force acts against and overcomes the force exerted by theresilient member 18, which tends to hold the rotation member 15 and thestop member 20 in abutment with the drive member 16, as describedpreviously. Consequently, the resilient member 18 is axially biased whenthe drive member 16 and the stop member 20 are displaced distally withrespect to the rotation member 15 for decoupling the drive member 16 andthe rotation member 15. When the drive member 16 and, hence, the stopmember 20, are moved with respect to the rotation member 15, the stopmember 20 and the drive member 16 are held in abutment due to the forceexerted by the resilient member 18. Relative movement between the drivemember 16 and the rotation member 15, i.e. decoupling movement, may leadto a gap (see FIGS. 4 and 5) between the drive member 16 and therotation member 15. The gap may have a size such that the toothing 21 ofthe rotation member 15 and the toothing 22 of the drive member 16 areout of engagement, i.e. the rotation member 15 and the drive member 16are disengaged. Accordingly, the relative displacement should be greaterthan or at least equal to the depth of a respective tooth of toothings20, 21.

When the drive member 16 and the rotation member 15 are decoupled, thedrive member 16 and the rotation member 15 are no longer rotationallylocked in the first direction. When the drive member 16 and the rotationmember 15 are decoupled, the device 1 is in the correction mode (seealso FIG. 5). In the correction mode, the rotation member 15 may rotatein the first rotational direction with respect to the drive member 16.Accordingly, the set dose may be corrected without movement of the drivemember 16 and, hence, of the piston rod 14.

For switching from the correction mode into the delivery mode or backinto the setting mode, the respective correction member 7 may bereleased. The spring member arranged between the disc-like portion 7Aand the protruding portion 7B relaxes radially outwardly. Hence, therespective correction member 7 is automatically displaced radiallyoutwardly such that there is no longer mechanical interaction betweenthe correction member 7 and the interaction element 17. Consequently,the correction force is no longer exerted onto the drive member 16 forkeeping the drive member 16 and the rotation member 15 out ofengagement.

Thus, the resilient member 18 may relax axially. This may lead to arelative movement between the drive member 16 and the rotation member 15in the opposite direction as for decoupling, for coupling, in particularengaging, the drive member 16 and the rotation member 15. In particular,the drive member 16 and, hence, the stop member 20 are driven in theproximal direction by the energy which was previously stored within theresilient member 18 during the decoupling.

When the rotation member 15 and the drive member 16 are brought backinto engagement, the corrected dose can be delivered or the device 1 maybe put away with an unintentionally set dose being unset.

FIG. 3 schematically shows a perspective sectional view of the drugdelivery device shown in FIG. 1 in the setting mode.

For setting a dose, the user displaces the dose member 6 in the proximaldirection (arrow 25) with respect to the housing 5. To do so, the usermay grip dose button 6A and pull it in the proximal direction, forexample. Dose member 6 moves proximally also with respect to therotation member 15.

Proximal displacement of the dose member 6 with respect to the housing 5is converted into rotational movement of the rotation member 15 in thesecond rotational direction with respect to the housing 5, in particularon account of the threaded engagement of dose member 6 and rotationmember 15. The rotation member 15 also rotates with respect to the drivemember 16 and with respect to the stop member 20. An audible and/ortactile feedback may be given to the user when the next tooth oftoothing 22 of the drive member 16 is engaged by a respective tooth oftoothing 21 of the rotation member 15.

As the piston rod 14 is coupled to the drive member 16 and rotation inthe second rotational direction of the drive member 16 would cause thepiston rod 14 to be displaced in the proximal direction, the piston rod14 is prevented from being driven in the proximal direction byinteraction of stop member 20 and drive member 16. Dose accuracy can beincreased in this way.

The set dose may be visible through a window aperture (not explicitlyshown) in the housing 5. When the user realizes that the selected doseis too high or a (fixed) dose was erroneously set, the user may correctthe set dose by switching the device 1 into the correction mode.

FIG. 4 schematically shows a perspective sectional view of the drugdelivery device of FIG. 3 while switching into the correction mode.

FIG. 5 schematically shows a perspective sectional view of the drugdelivery device of FIG. 4 in the correction mode.

When the user wants to correct the previously set dose (see FIG. 3) theuser pushes onto the respective correction member 7 (arrow 26) forswitching into the correction mode. As described in connection with FIG.2, radial inward movement of the correction members 7 with respect tothe housing 5 is converted into relative decoupling movement of thedrive member 16 and the rotation member 15.

When the drive member 16 and the rotation member 15 are decoupled, e.g.when the device 1 is in the correction mode, the dose member 6 can bedisplaced in the distal direction with respect to the housing 5 forcorrecting the previously set dose (see arrow 27). The dose member 6 isdisplaced distally until the desired dose size is reached, which may bedisplayed in the window aperture (not explicitly shown) of the housing5, or until the dose is unset.

During the correction movement of the dose member 6, the rotation member15 rotates in the first rotational direction with respect to the housing5. As the rotation member 15 and the drive member 16 are decoupled, thedrive member 16 is prevented from rotating in the first rotationaldirection. Accordingly, the piston rod 14, which is driven by the drivemember 16, is prevented from movement with respect to the housing 5. Inthis way, the set dose can easily be corrected and waste of drug 11 maybe avoided.

When the dose was corrected, e.g. the desired dose size is displayed inthe window aperture, the user may switch the device 1 from thecorrection mode into the delivery mode by releasing the respectivecorrection member 7. Thereby, the rotation member 15 and the drivemember 16 are brought back into engagement, as it was described inconnection with FIG. 2. Hence, the rotation member 15 and the drivemember 16 are again rotationally locked in the first rotationaldirection for dispensing the corrected dose.

For dispensing the corrected dose, the dose button 6A is pushed and,hence, the dose member 6 is displaced in the distal direction withrespect to the housing 5. The rotation member 15 accordingly rotates inthe first rotational direction with respect to the housing 5. The drivemember 16 follows rotational movement of the rotation member 15 in thefirst rotational direction with respect to the stop member 20. Anaudible and/or tactile feedback may be given to the user when the nexttooth of toothing 24 of the stop member 20 is engaged.

Rotational movement of the drive member 16 in the first rotationaldirection is converted into rotational movement of the piston rod 14 inthe first rotational direction. Said movement is converted into movementof the piston rod 14 in the distal direction due to the threadedengagement of the piston rod 14 and the housing 5. Accordingly, the bung12 is displaced in the distal direction with respect to the cartridge 3and the corrected dose of the drug 11 is dispensed from the cartridge 3.

As described above, the rotation member 15 and the drive member 16 maybe decoupled due to movement of the drive member 16 and, hence, of thestop member 20, with respect to the rotation member 15. Alternatively,in an embodiment not explicitly shown in the drawings, relative movementbetween the rotation member 15 and the drive member 16 for decouplingthe drive member 16 and the rotation member 15 may comprise axial, inparticular proximal, movement of the rotation member 15 with respect tothe drive member 16 and, in particular, with respect to the stop member20. In this case, the drive member 16 and the stop member 20 may remainstationary with respect to the housing 5.

When the rotation member 15 is moved relatively to the drive member 16,the interaction element 17 or an additional interaction element may bearranged at the rotation member 15. Accordingly, the oblique outer face17A may be adapted to mechanically interact with the tip of theprotruding portion 7B such that radial inward movement of the correctionmember 7 with respect to the housing 5 is converted into proximalmovement of the rotation member 15 with respect to the drive member 16and the stop member 20. However, movement of the rotation member 15 withrespect to the drive member 16 may cause a movement of the dose member 6during unsetting or correcting the dose. Movement of the dose member 6may irritate the user. When the drive member 16 is moved with respect tothe rotation member 15, said movement of the dose member 6 may beavoided.

Other implementations are within the scope of the following claims.Elements of different implementations may be combined to formimplementations not specifically described herein.

REFERENCE NUMERALS

1 Drug delivery device

2 Cartridge holder

3 Cartridge

4 Engagement means

5 Housing

6A Dose button

6 Dose member

7 Correction member

7A Disc-like portion

7B Protruding portion

8 Distal end

9 Proximal end

10 Outlet

11 Drug

12 Bung

13 Bearing member

14 Piston rod

14A Thread

15 Rotation member

15A Thread

16 Drive member

17 Interaction element

17A Surface

17B Skirt

18 Resilient member

19 Main longitudinal axis

20 Stop member

21 Tooth

22 Tooth

23 Tooth

24 Tooth

25 Arrow

26 Arrow

27 Arrow

28 Counterpart

1. An assembly for a drug delivery device (1) comprising a housing (5),a rotation member (15), the rotation member (15) being adapted to berotated with respect to the housing (5) in a first rotational directionfor delivering a dose of a drug (11), and a drive member (16), the drivemember (16) being coupleable to the rotation member (15) for deliveringthe dose, at least one correction member (7), wherein, in a deliverymode, the drive member (16) and the rotation member (15) are coupledsuch that the drive member (16) follows rotational movement of therotation member (15) in the first rotational direction due to mechanicalinteraction of the rotation member (15) and the drive member (16), andwherein, in a correction mode, the rotation member (15) and the drivemember (16) are decoupled such that the rotation member (15) isrotatable in the first rotational direction with respect to the drivemember (16), wherein, for switching from the delivery mode into thecorrection mode, the correction member (7) is movable with respect tothe housing (5), and wherein the assembly is configured such thatmovement of the correction member (7) with respect to the housing (5) isconverted into a relative movement between the drive member (16) and therotation member (15) for decoupling the drive member (16) and therotation member (15).
 2. The assembly of claim 1, wherein, in a settingmode, the rotation member (15) is adapted to be rotated in a secondrotational direction with respect to the drive member (16) for setting adose of a drug (11), and wherein, in the delivery mode and in thesetting mode, the drive member (16) and the rotation member (15) arecoupled to one another by means of a uni-directional friction clutchmechanism, which is configured to prevent relative rotational movementbetween the rotation member (15) and the drive member (16) duringrotation of the rotation member (15) in the first rotational directionand to permit relative rotational movement between the rotation member(15) and the drive member (16) during rotation of the rotation member(15) in the second rotational direction.
 3. The assembly of claim 2,comprising a stop member (20), wherein the drive member (16) and thestop member (20) are coupled to one another by an other uni-directionalfriction clutch mechanism, which is configured to permit relativerotational movement between the stop member (20) and the drive member(16) during rotation of the rotation member (15) in the first rotationaldirection.
 4. The assembly of claim 3, wherein the other uni-directionalfriction clutch mechanism is configured to prevent relative rotationalmovement between the stop member (20) and the drive member (16) duringrotation of the rotation member (15) in the second rotational direction.5. The assembly according to any of the previous claims, comprising apiston rod (14), wherein the drive member (16) and the piston rod (14)are rotationally locked with each other.
 6. The assembly of claim 3 andclaim 4, wherein, for switching into the correction mode, the drivemember (16) and the rotation member (15) are moved relatively to eachother and with respect to the piston rod (14) for decoupling therotation member (15) and the drive member (16) and, wherein, when thedrive member (16) is moved with respect to the rotation member (15), thestop member (20) is moved together with the drive member (16).
 7. Theassembly according to any of claims 3 to 6, wherein, in the deliverymode and in the setting mode, the rotation member (15) and the stopmember (20) are held in abutment with the drive member (16) by a forceprovided by a resilient member (18).
 8. The assembly of claim 7,wherein, for switching into the correction mode, a correction force mustbe applied acting against the force exerted by the resilient member(18).
 9. The assembly according to any of the previous claims, whereinat least one of the drive member (16) and the rotation member (15)comprises at least one interaction element (17), and wherein, forswitching into the correction mode, the correction member (7)mechanically interacts with the interaction element (17) to convertmovement of the correction member (7) into relative movement between thedrive member (16) and the rotation member (15).
 10. The assembly ofclaim 9, wherein the interaction element (17) has an oblique outer face(17A), and wherein the correction member (7) exerts a radially directedforce onto the interaction element (16), the force being converted intoan axially directed force by mechanical cooperation of the correctionmember (7) and the oblique outer face (17A).
 11. The assembly accordingto claim 9 or claim 10, wherein the correction member (7) is securedagainst rotational movement with respect to the housing (5) and againstmovement along a main longitudinal axis (19) of the housing (5), andwherein the correction member (7) and the interaction element (17)axially overlap.
 12. The assembly according to any of the previousclaims, wherein the correction member (7) is externally actuatable. 13.The assembly according to any of the previous claims, wherein thecorrection member (7) is a resilient member or a resiliently mountedmember.
 14. The assembly according to any of the previous claims,comprising two equally configured correction members (7), the correctionmembers (7) being oppositely disposed.
 15. A drug delivery device (1)comprising the assembly according to any of the previous claims, furthercomprising a cartridge (3), the cartridge (3) holding a plurality ofdoses of a drug (11), wherein the assembly provides a dose correctionmechanism allowing for correcting a set dose.